Answers are grounded in this paper and cite their sources.
Secondary data analysis identifies high rates of causally associated adverse events after measles-rubella vaccination, suggesting a need for improved management strategies.
Background: Measles–rubella (MR) vaccine is given both routinely and in campaign mode. Children between the ages of 9 months and 15 years received the MR vaccination as part of a campaign in 2017. The minor, severe, and serious adverse events following immunization (AEFIs) were reported during the campaign. Following the investigation of these events, a group of specialists did the causality assessment. The causality assessment reports are publicly accessible on the Ministry of Health and Family Welfare (MoHFW)’s website. Methods: The reports of causally assessed severe and serious AEFIs following MR vaccination during campaign were retrieved from the website of the MoHFW for the period July 2017 to September 2024. The descriptive analysis of these reports was done. Results: A total of 776 serious/severe AEFI cases were analyzed for causality assessment classification. Out of 776 cases, 639 (82.3%) were causally associated, 4 (0.5%) were indeterminate, 127 (16.4%) were coincidental, and 6 (0.8%) were unclassifiable. Out of 639 cases, the majority (77%) of the causally assessed AEFI belonged to immunization anxiety-related AEFI (A4 category). The majority (64%) of the AEFI reports were present in adolescents (10–19 years). More than half of the cases (61%) were female. Conclusion: The anxiety-related AEFIs interfere with immunization campaigns, lowering public faith in vaccines and affecting vaccination coverage. The policies to avoid and successfully manage these anxiety-related AEFI should be implemented effectively, so that public confidence is maintained in the vaccination drives.
No takes yet. Share an insight, caveat, or question.
Gupta et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: